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A B S T R A C T
Background: Catechol-O-methyltransferase (COMT) polymorphisms play an essential role in dopamine avail-
ability in the brain. However, there has been no study investigating whether a functional four-SNP (rs6269-
rs4633-rs4818-rs4680) haplotype is associated with aﬀective symptoms over the life course.
Methods: We tested this using 2093 members of the Medical Research Council National Survey of Health and
Development (MRC NSHD), who had been followed up since birth in 1946, and had data for COMT genotypes,
adolescent emotional problems (age 13–15) and at least one measure of adult aﬀective symptoms at ages 36, 43,
53, or 60–64 years. First, diﬀerences in the levels of aﬀective symptoms by the functional haplotype using SNPs
rs6269, rs4818, and rs4680 were tested in a structural equation model framework. Second, interactions between
aﬀective symptoms by COMT haplotype were tested under an additive model. Finally, a quadratic regressor
(haplotype2) was used in a curvilinear model, to test for a possible inverted-U trend in aﬀective symptoms
according to COMT-related dopamine availability.
Results: Women had a signiﬁcant interaction between COMT haplotypes and adolescent emotional problem on
aﬀective symptoms at age 53. Post hoc analysis showed a signiﬁcant positive association between adolescent
emotional problems and aﬀective symptoms at age 53 years in the middle dopamine availability group (valA/
valB or met/met; β = .11, p = .007). For men, no signiﬁcant interactions were observed.
Conclusions: Combination of the COMT functional haplotype model and inverted-U model may shed light on the
eﬀect of dopaminergic regulation on the trajectory of aﬀective symptoms over the life course.
1. Introduction
Aﬀective symptoms are common psychological occurrences that
mainly emerge in early adolescence (Patton et al., 2014; Thapar et al.,
2012). Although most episodes remit and generally decrease with age
(Patton et al., 2014), some people with adolescent aﬀective symptoms
will also experience aﬀective symptoms in adulthood (Colman et al.,
2014; Thapar et al., 2012). Genetic factors play an important role in the
recurrent risk of aﬀective symptoms, with speciﬁc genetic variants
contributing to the onset and severity of these disorders via interactions
with adolescent experiences (Antypa et al., 2013). Gene-environment,
or more speciﬁcally, gene-behaviour interaction research has great
potential to elucidate the aetiology of aﬀective disorders (Rutter et al.,
2006) and facilitate more personalised and, therefore, more eﬀective
intervention strategies to mitigate course of mental illness (Klengel and
Binder, 2011).
Dopamine is a neurotransmitter that regulates a wide range of
psychological function including motivation and reward activity
(Antypa et al., 2013). Catechol-O-methyltransferase (COMT) is an en-
zyme in catecholamine metabolism that plays an essential role in brain
dopamine availability. There are numerous genetic association studies
implicating the COMT rs4680 (Val158Met) polymorphism in the in-
cidence of major depression and anxiety disorders, and response to
antidepressants (Antypa et al., 2013; Gatt et al., 2015). A population
based study found that Met-allele carriers with childhood family-re-
lated adversities were more likely to have clinical depressive symptoms
(Aberg et al., 2011). On the other hand, in a prospective longitudinal
study neuroticism (a personality trait that highly correlates with
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depression) signiﬁcantly increased from adolescence to adulthood in
female Val homozygotes, but not in Met-allele carriers (Lehto et al.,
2013). These results suggest that life course trajectories of aﬀective
symptoms can be modiﬁed by the COMT polymorphisms; however,
results are inconsistent.
A recent protein structure study showed that COMT activity is
converted into three enzyme levels by the four-SNP (rs6269-rs4633-
rs4818-rs4680) (Nackley et al., 2006). This functional haplotype is as-
sociated with pain sensitivity, probably because COMT regulates ca-
techolamine and encephalin levels in the brain (Aggarwal et al., 2011;
Diatchenko et al., 2005).
Studies have shown that middle dopamine availability by the COMT
haplotype (valA/valB or met/met) was associated with the highest
verbal IQ performance at age 8 years (Barnett et al., 2009) but not with
cognitive performance at age 15 years (Gaysina et al., 2013). Another
study found that adolescents and young adults with middle dopamine
availability (valA/met) had the largest white matter volume in the
prefrontal cortex (Liu et al., 2010). This suggests that cognitive function
may be associated with an optimal dopamine density in the prefrontal
cortex, according to an inverted-U shape model (Takahashi, 2013). It
therefore may be possible that this pattern is also observed for aﬀective
symptoms; however, to the best of our knowledge this has not been
investigated. However, to the best of our knowledge this has not been
investigated, and evidence is lacking on how life course trajectories of
aﬀective symptoms are modiﬁed by COMT.
The MRC National Survey of Health and Development (NSHD) is the
oldest prospective birth cohort study in the world, beginning in 1946 in
England, Scotland, and Wales. This cohort has measured symptoms of
aﬀective symptoms from adolescence through middle age (Colman
et al., 2007). In the present study, we tested whether the COMT four-
SNP functional haplotype was associated with aﬀective symptoms from
adolescence to old age under an additive and curvilinear model.
2. Methods
2.1. Participants
The NSHD initially consisted of a socially-stratiﬁed sample of 5362
children from all single births within marriage during 1 week in March
1946 in England, Scotland, and Wales. Reﬂecting the demographic
characteristic of the British population in 1946, all of study members
are of White British ethnicity. At ages 13 and 15 years, 3927 study
members were rated for emotional problems by their teachers
(Supplementary Fig. S1). At age 36, 43, 53, and 60–64 years, 3293,
3157, 2902, and 2185 study members, respectively, responded to
questions eliciting aﬀective symptoms (see Measures). Blood samples
for DNA extraction were collected from 2756 study members at age 53
years, and genotyping were conducted on 2498 of these samples. From
these denominators the analytic sample consisted of 2093 study mem-
bers with non-missing data for COMT genotyping, adolescent emotional
problems, and at least one measure of adult aﬀective symptoms. Those
included in the analyses were more likely to be female (p = .003) and
had fewer adolescent emotional problems (p< .004) compared to those
excluded. However, there were no diﬀerences at the 5% level in af-
fective symptoms at ages 36, 53 and 60–64 years. At ages 53 and 60–64
the cohort was representative in most respects to the national popula-
tion of a similar age, as compared to Census (Staﬀord et al., 2013;
Wadsworth et al., 2003) and Integrated Household Survey data
(Staﬀord et al., 2013).
Ethical approval for this study was obtained from the Greater
Manchester Central and Scottish A Research Ethics committees. All
study members gave written informed consent.
2.2. Measures
2.2.1. Aﬀective symptoms
Behaviour, mood and emotions in adolescence (at ages 13 and 15)
were rated by teachers using forerunners of the Rutter A scale (Elander
and Rutter, 1996; Rutter et al., 1970). These ratings have been classi-
ﬁed into 3 behavioral dimensions reﬂecting emotional (internalizing)
problems (e.g. extremely fearful); conduct (externalizing) problems
(e.g. a quarrelsome and aggressive child); and self-control (e.g. a poor
worker or lazy) (Koike et al., 2016; Nishida et al., 2014; Xu et al.,
2013). We used the emotional problem score to represent adolescent
emotional problems, which was calculated from the standardized mean
of the factor scores at both ages, with appropriate goodness of ﬁt sta-
tistics indicating satisfactory ﬁt (Xu et al., 2013). In adulthood aﬀective
symptoms were assessed at ages 36, 43, 53 and 60–64. Aﬀective
symptoms were assessed at age 36 years using a short version of the
Present State Examination (PSE), a clinically validated interview ad-
ministrated by trained nurses (range 1―7) (Wing et al., 1974). The
index of association (which correlates highly with kappa) between
nurse and expert ratings at the syndrome level based on 526 recorded
NSHD interviews averaged 0.71; and agreement was 0.74 for Index of
Deﬁnition assignment (Rodgers and Mann, 1986). The index of deﬁ-
nition score was intended to detect nervous or emotional symptoms and
had statistically one factor (Rodgers and Mann, 1986). At age 43 years,
the Psychiatric Symptom Frequency (PSF) scale was administered by
interview using an 18-item questionnaire (range 0―90, Cronbach's α=
.88) (Lindelow et al., 1997). For these assessments, we used the original
scores. At ages 53 and 60–64 years, the 28-item version of the self-
report General Health Questionnaire (GHQ-28) was used (Goldberg and
Hillier, 1979). Each item was scored using a 4-level Likert scale recoded
to 0-0-1-1 and re-summed (range 0―28, α= .92 and .89, respectively).
The GHQ-28 had statistically four factors as well as one factor which
was correlated with other aﬀective symptom measures such as the Beck
Depression Inventory and the Center for Epidemiological Studies De-
pression scales (Sakakibara et al., 2009).
2.2.2. Genotyping
DNA was extracted and puriﬁed from whole blood using the
Puregene DNA Isolation Kit (Flowgen, Leicestershire, UK) according to
the manufacturer's protocol (Rousseau et al., 2006). Since a SNP rs4633
does not change the amino acid sequence (CAC [histidine] to CAT
[histidine]) well-known as a benign allele and contributes to no al-
teration of dopamine availability, SNPs rs6269, rs4818, and rs4680
were typed by using the KASPar system by KBioscience, UK (http://
www.kbioscience.co.uk). Integrity of the genotyping was checked by
genotypeing frequency, concordance between duplicate samples
(> 95% concordance) and Hardy-Weinberg equilibrium (p>0.05).
2.3. Statistical analysis
Three SNPs were in linkage disequilibrium (rs6269―rs4680 and
rs4818―rs4680, r2 = 0.72; rs6269―rs4818, r2 = 0.97), and were set
into three functional haplotypes (valA, G-G-G; met, A-C-A; valB, A-C-G)
as suggested in the original study (Nackley et al., 2006). Since the
met allele has middle dopamine availability in-between the valA and
valB allele levels (Nackley et al., 2006), study members were then ca-
tegorized into ﬁve diplotype groups: the highest dopamine availability
(valA/valA), second highest (valA/met), middle (valA/valB or met/
met), second lowest (valB/met), and lowest (valB/valB) (Barnett et al.,
2009; Gaysina et al., 2013). We tested for the presence of an inverted-U
trend in aﬀective symptoms according to the COMT haplotype. First, a
saturated structural equation model (SEM) was ﬁtted for the trajectory
of aﬀective symptoms, including the sex interactions (Fig. 1) as pre-
vious studies have shown sex-speciﬁc eﬀects (Hatch et al., 2007). In-
teractions were calculated using the numerical variables (sex: male=1,
female=2; haplotype: the highest=1, the lowest=5) and the “indProd”
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function in R. The estimation of the model was conducted using robust
maximum likelihood estimation, and missing values were handled
using full information maximum likelihood (FIML). Model ﬁt indicated
adequate ﬁt (CFI)> 0.90, Tucker-Lewis index (TLI)> 0.90, root mean
square error of approximation (RMSEA)<0.10, and standardized root
mean square residual (SRMR)<0.08. SEM was performed using the
“lavaan” package version 0.5–18 in R version 3.2.1 (R Core Team,
2014; Rosseel, 2012). Where sex interactions were signiﬁcant in the
model, further analyses were stratiﬁed by sex.
Next, we ﬁtted the SEM model to test the trajectory of aﬀective
symptoms by the COMT functional haplotype under an additive curvi-
linear model using a quadratic regressor (haplotype2), to test for a
possible inverted-U trend in symptoms according to dopamine avail-
ability (Fig. 1). Signiﬁcant interactions between all associations for
adolescent emotional problems and adult aﬀective symptoms by the
COMT haplotype were further tested using multiple-group analysis for
the initial SEM model to estimate the correlations within each genotype
group, using equal loadings, means, residuals, and intercepts for the
non-signiﬁcant eﬀect of genetic modiﬁcation.
3. Results
Descriptive statistics showed that female study members had higher
scores than males on all aﬀective measures, as expected (Table 1).
There were no signiﬁcant gender diﬀerences in the distribution of the
COMT functional haplotypes. There was no signiﬁcant diﬀerence in any
measure of aﬀective symptoms between functional haplotype (Table 2
and Supplementary Tables S1 and S2).
The initial SEM model to test the eﬀect of sex did not have a good ﬁt
(n = 2093, χ2 = 98.0, p< .001, CFI = .86, TLI = 0.52, RMSEA =
.065, SRMR = 0.057) and showed a main eﬀect of sex in all aﬀective
symptom measures, as well as sex interactions with the adolescent
emotional problems on the GHQ score at age 60–64, and with the PSF
score at age 43 on the GHQ score at age 60–64.
The SEMmodels to test the COMT haplotype eﬀect had a good ﬁt for
men (n = 1045, χ2 = 12.6, p = .90, TLI = 1.18, CFI = 1.0,
RMSEA< .001, SRMR = 0.019) and women (n = 1048, χ2 = 21.7, p
= .36, CFI = .99, TLI = 0.98, RMSEA = .009, SRMR = 0.016). The
model for men showed no main eﬀect of the COMT haplotype or sig-
niﬁcant interaction by the haplotype (p> .05). The model for women
showed no main eﬀect of the haplotype but showed a signiﬁcant in-
teraction between adolescent emotional problems and the haplotype (β
= .25, p = .036) and haplotype2 (β = −.27, p = .026) on GHQ score
at age 53 years (Fig. 2). Post hoc analysis showed a signiﬁcant positive
association between adolescent emotional problems and GHQ score at
age 53 years only in the middle dopamine availability group (valA/valB
or met/met; β= .11, p= .007; Fig. 3a), while there were no signiﬁcant
associations in the other haplotype groups (highest [valA/valA]: β =
−.01, p = .95; second highest [valA/met]: β = .09, p = .080; second
lowest [valB/met]: β =−.05, p = .44). We excluded females with the
lowest dopamine availability group (valB/valB) from this analysis be-
cause this group was very small (n = 7). A signiﬁcant interaction was
not observed between adolescent emotional problems and the haplo-
type on GHQ score at age 60–64 years (Fig. 3b).
4. Discussion
A population representative prospective birth cohort study revealed
that the COMT functional haplotype modiﬁes the association between
adolescent emotional problems and adult aﬀective symptoms. These
results suggest that females with a middle level of dopamine avail-
ability and high adolescent emotional problems are more likely to have
recurrent aﬀective symptoms in midlife. To the best of our knowledge,
this is the ﬁrst study to show that the COMT functional haplotype can
alter aﬀective symptom trajectory over approximately 50 years from
adolescence to late midlife. These results suggest that a combination of
the functional haplotype and inverted-U shape models can reveal ge-
netic inﬂuence on the trajectory of aﬀective symptoms through the life
Fig. 1. Initial structural equation model (SEM) ﬁtted to the
trajectory of aﬀective symptoms. Abbreviations: PSE, a short
version of the Present State Examination; PSF, the Psychiatric
Symptom Frequency scale; GHQ-28, the 28-item version of the
General Health Questionnaire. An SEM was set to test the tra-
jectory of aﬀective symptoms shown by black arrows and the
main eﬀects of a modiﬁer and the interactions of aﬀective
symptoms by a modiﬁer shown by red arrows. First, we used sex
as a modiﬁer to explore sex diﬀerence in the trajectory of aﬀective
symptoms. Second, we used the COMT functional haplotype
under an additive curvilinear model using a quadratic regressor
(haplotype2), to test for a possible inverted-U trend in aﬀective
symptoms according to dopamine availability. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
Table 1
Demographic characteristics and genotypes in this study.
Total (n = 2093) Male (n = 1045) Female (n = 1048) Gender diﬀerences P value3)
Aﬀective symptoms, mean [SD]
Adolescents emotional problem1) −0.06 [0.97] −0.15 [0.95] 0.02 [0.98] < .001
PSE index of deﬁnition score at age 36 years 1.9 [1.2] 1.7 [1.1] 2.1 [1.3] < .001
PSF total score at age 43 years 10.4 [10.1] 8.7 [8.7] 12.1 [11.1] < .001
GHQ-28 score at age 53 years 2.5 [4.4] 1.9 [3.8] 3.1 [4.9] < .001
GHQ-28 score at age 60–64 years 2.3 [3.7] 1.7 [3.0] 2.8 [4.3] < .001
COMT functional haplotype2), n (%)
Highest (valA/valA) 355 (17.1) 183 (17.7) 172 (16.5) .94
Second highest (valA/met) 861 (41.5) 432 (41.7) 429 (41.3)
Middle (valA/valB or met/met) 664 (32.0) 326 (31.5) 338 (32.5)
Second lowest (valB/met) 182 (8.8) 88 (8.5) 94 (9.0)
Lowest (valB/valB) 14 (0.7) 7 (0.7) 7 (0.7)
Abbreviations: PSE, the Present State Examination; PSF, the Psychiatric Symptom Frequency; GHQ-28, the 28 item version of the General Health Questionnaire.
1) Z scores.
2) The functional haplotype was deﬁned by three SNPs (rs6269, rs4818, and rs4680), and each participant was categorized into ﬁve in accordance with dopamine availability.
3) Gender diﬀerences were tested using t-test. Bold shows 5% level signiﬁcance.
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course.
The present study showed that females with middle dopamine
availability (valA/valB or met/met) and evidence of emotional pro-
blems in adolescence were more likely to have aﬀective symptoms at
age 53. There are several possible reasons why the association occurred
only in middle-aged females. Previous studies have suggested that those
with middle dopamine ability have optimal childhood cognition and
larger volume in the prefrontal cortex (Barnett et al., 2009; Liu et al.,
2010). In NSHD, childhood cognition was inversely associated with the
GHQ-28 at age 53 score after adjusting for educational attainment,
early socioeconomic status (SES) and adverse circumstances, and adult
SES, adverse circumstances and negative health behaviors (Hatch et al.,
2007), but only in women. Second, the menopausal syndrome, trig-
gered by reduced estrogen, may be associated with the COMT haplo-
type, since dopamine also inﬂuences sex hormone metabolism in the
hypothalamic-pituitary-adrenal (HPA) axis, leading to reduced level of
estrogen (Gordon et al., 2015). However, the relationship between es-
trogen level modiﬁed by COMT polymorphisms and psychological
symptoms is complex, and requires further investigation. One reason
why the modiﬁcation disappeared again at age 60–64 years is that the
decrease of sample size from age 53 years may have reduced the power
and increase bias. Another reason is that after the critical period above
explained, the increase of physical diseases and environmental factors
such as retirement and bereavement may aﬀect the psychological pro-
blems greater.
In the present study, two biological-based models, a curvilinear
model stratiﬁed by the functional haplotype, may elucidate the asso-
ciation between COMT genotypes and aﬀective symptoms. In
particular, the association for the highest dopamine availability (valA/
valA) group was in the opposite direction to that in the middle (valA/
valB) group, both of which were typed as val/val on rs4680 genotype. A
similar pattern was seen in the second highest (valA/met) and the
second lowest (valB/met) groups. There have been numerous studies
conducted using the COMT val158met polymorphism in psychiatry;
however, results are inconsistent. Future gene-environment interaction
researches will be conducted by using combinations of biological
ﬁndings not merely gene type.
Several limitations should be considered. First, the disproportionate
loss to follow-up such as greater adolescent emotional problem, which
is typically associated with lower social advantage and poorer health,
could have potentially aﬀected the results. Second, although the study
remained broadly representative of the mainland British population,
the study sample is of White British ethnicity. While this reﬂects the
demographic characteristic of the British population in 1946, the
ﬁndings of this study cannot necessarily be extrapolated to other ethnic
groups. Third, we did not use other COMT SNPs such as the rs737865
polymorphism, which is associated with cognitive function (Gaysina
et al., 2013) and may aﬀect the present ﬁndings. Forth, the diﬀerent
symptom scales over time could have aﬀected the results. Fifth, power
may still be limited for a genetic study although we used a relatively
large sample, where power analysis showed that 0.079 of the slope
could be detected in linear bivariate regression (n = 2093, α = .05, β
= .95, two-tailed).
In conclusion, a population representative prospective birth cohort
study revealed that females with middle dopamine availability by
COMT functional haplotype and high adolescent emotional problem
Table 2
Presence of aﬀective symptoms and genotypes.
Highest (valA/valA)
(n = 355)
Second highest (valA/
met) (n = 861)
Middle (valA/valB or
met/met) (n = 664)
Second lowest (valB/
met) (n = 182)
Lowest (valB/
valB) (n = 14)
Group diﬀerences P
value1)
Aﬀective symptoms, mean [SD]
Adolescents emotional
problem
−0.04 (0.97) −0.05 (0.98) −0.09 (1.00) −0.09 (0.87) −0.28 (0.74) .83
PSE index of deﬁnition score at
age 36 years
2.0 (1.2) 1.9 (1.2) 1.9 (1.2) 1.9 (1.2) 1.9 (1.3) .62
PSF total score at age 43 years 10.9 (9.2) 10.3 (10.6) 10.3 (9.8) 10.1 (10) 11.2 (8.3) .86
GHQ-28 score at age 53 years 2.6 (4.4) 2.4 (4.4) 2.6 (4.4) 2.5 (4.2) 1.7 (3.0) .78
GHQ-28 score at age 60–64
years
2.4 (3.8) 2.2 (3.7) 2.2 (3.7) 2.3 (3.7) 2.5 (3.2) .95
The results for men and women are shown in supplementary Tables S1 and S2, respectively.
1) Group diﬀerences were tested using ANOVA.
Fig. 2. The interaction of aﬀective symptoms by the COMT
haplotype. Abbreviations: PSE, a short version of the Present
State Examination; PSF, the Psychiatric Symptom Frequency
scale; GHQ-28, the 28-item version of the General Health
Questionnaire. Only signiﬁcant relationships and interactions are
shown with standardized coeﬃcients (*p< .05, **p< .01,
***p< .001). The trajectory of aﬀective symptoms and the in-
teractions between adolescent emotional problems and the COMT
functional haplotype (red arrow) are shown for men and women.
The interaction between adolescent emotional problems and adult
aﬀective symptoms at age 53 years by the haplotype in women
was indicated under an additive curvilinear model (Haplotype: β
= .25, p = .036; haplotype2: β = −.27, p = .026). (For inter-
pretation of the references to color in this ﬁgure legend, the
reader is referred to the web version of this article.)
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were more likely to have aﬀective symptoms at age 53 years. These
results indicate that the combination of the COMT functional haplotype
and inverted-U models may shed further light on dopamine regulation
of aﬀective symptoms over the life course.
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